Eli Lilly and Co.

Exporter
Lilly Corporate Ctr., Indianapolis, IN 46285-0001, United States
(317)276-2000, (317)277-6579 fax, http://www.lilly.com

Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Eli Lilly and Company was incorporated in 1901, in Indiana, to succeed the drug manufacturing business founded in 1876 by Colonel Eli Lilly. The company develops, manufactures, and sells products in one business segment, pharmaceutical products. There is also an animal health business segment, Elanco. Pharmaceutical research and development focuses on four therapeutic categories: central musculoskeletal disorders, cancer, and cardiovascular diseases. As of late 2008, the company had 15 production and distribution facilities in the United States and Puerto Rico, as well as production and distribution facilities in 15 countries outside the United States and Puerto Rico. Major production sites include facilities in France, Ireland, Spain, Brazil, Italy, and the United Kingdom. Products were sold in approximately 135 countries. For research and development the company has facilities in Indianapolis, San Diego, New York City as well as facilities abroad in the United Kingdom, Canada, Singapore and Spain. Among patented products produced and sold by the company are Humalog, Evista, Alimta, Byetta, Cialis, Cymbalta, Erbitux, Forteo, Gemzar, Zyprexa, and Prozac. Lilly has acquired all of the outstanding stock of several compaies in recent years such as Hypnion Inc., Ivy Animal Health Inc., and ICOS Corp. in 2007 and SGX Pharmaceuticals in 2008. More

Manufacturing: Pharmaceuticals, medical instruments, diagnostic and animal health products, research and development.